High expressions of CXCL10 and STAT2, which are correlated with activation of T-cell pathways and tumor infiltration of Th1 and CD8+ T cells, are good prognostic biomarkers for oral cancer patients. The gene discussed is STAT2; the disease is lip and oral cavity carcinoma.